Steven A Kriegsman
CIK 1197482 · Chief Executive Officer · last filed 2020-08-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GALE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SCHENECTADY, NY 12308
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LadRx Corp (CYTXW) Delisted | CEO | 387,597 | — | — | $50.9K | 13 | 2017-12-19 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | Director | 8,500 | — | — | -$2.93M | 5 | 2015-06-23 |
| SELLAS Life Sciences Group, Inc. (RXII) Delisted | Director | 17 | — | — | -$931.0K | 51 | 2011-09-29 |
| LadRx Corp (CYTR) Delisted | Chief Executive Officer | — | — | — | $0 | 3 | 2008-11-24 |
| Ontrak, Inc. (HYTM) Delisted | Director | — | — | — | $0 | 1 | 2008-07-18 |
| BRADLEY PHARMACEUTICALS INC (BDY) Delisted | Director | 25,000 | — | — | $0 | 1 | 2008-02-21 |
Recent Filings · Page 7 of 8
77 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-03-27 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −3,200 | -$12.6K | EDGAR |
| 2009-03-25 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −6,247 | -$23.8K | EDGAR |
| 2009-03-23 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −3,600 | -$12.7K | EDGAR |
| 2009-03-19 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −6,000 | -$22.2K | EDGAR |
| 2009-03-16 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −3,701 | -$11.7K | EDGAR |
| 2009-03-12 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −10,100 | -$32.7K | EDGAR |
| 2009-03-10 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −5,800 | -$17.7K | EDGAR |
| 2009-03-09 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −15,600 | -$61.4K | EDGAR |
| 2009-03-09 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Sell (S) | −2,100 | -$7.1K | EDGAR |
| 2009-01-20 | SELLAS Life Sciences Group, Inc. (RXII) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.